tiprankstipranks
Advertisement
Advertisement
SABS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSABS Upcoming Earnings Report: What to Expect?
1M ago
SAB Biotherapeutics Launches Major Equity Financing Offering
Premium
Company Announcements
SAB Biotherapeutics Launches Major Equity Financing Offering
2M ago
SAB Biotherapeutics 19.325M share Spot Secondary priced at $3.85
Premium
The Fly
SAB Biotherapeutics 19.325M share Spot Secondary priced at $3.85
2M ago
SAB Biotherapeutics announces additional Phase 1 data for SAB-142
PremiumThe FlySAB Biotherapeutics announces additional Phase 1 data for SAB-142
2M ago
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
Premium
Stock Analysis & Ideas
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
3M ago
SAB Biotherapeutics Updates SAB-142 Roadmap and Funding Outlook
Premium
Company Announcements
SAB Biotherapeutics Updates SAB-142 Roadmap and Funding Outlook
4M ago
SAB Biotherapeutics files $300M mixed securities shelf
PremiumThe FlySAB Biotherapeutics files $300M mixed securities shelf
4M ago
SAB Biotherapeutics Launches New $75 Million ATM Program
Premium
Company Announcements
SAB Biotherapeutics Launches New $75 Million ATM Program
4M ago
SAB Biotherapeutics: Favorable SAB-142 Safety Profile and De-Risked Phase 2b Design Underpin Buy Rating
Premium
Ratings
SAB Biotherapeutics: Favorable SAB-142 Safety Profile and De-Risked Phase 2b Design Underpin Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100